A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Single- and Multiple-Ascending Doses of MH-001 in Healthy Volunteers
Clinical trial NCT06780254 · COMPLETED
Trial details
- NCT number
- NCT06780254
- Sponsor
- Vespina Lifesciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-09
- Primary completion
- 2025-05-29
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.